-
-
-
-
-
-
-
Forte Biosciences, Inc. Announces Results and Provides Clinical Update
-
-
-
-
-
-
-
Forte Biosciences (FBRX) Reports Q3 Loss of $0.26
-
-
-
-
-
-
-
Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update
-
-
-
-
-
-
-
Forte Biosciences Inc. (FBRX) PT Raised to $90 at Ladenburg Thalmann, Following Earnings
-
-
-
-
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

